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Stent Redilation in Canine Models of Congenital Heart 
Disease: Pulmonary Artery Stenosis and Coarctation 
of the Aorta 
Alan M. Mendelsohn, MD, Parvin C. Dorostkar, MD, Catherine P. Moorehead, MS, 
Flavian M. Lupinetti, MD, Paul I. Reynolds, MD, Achi Ludomirsky, MD, Thomas R. Lloyd, MD, 
Kathleen Heidelberger, MD, and Robert H. Beekrnan 111, MD 
In a canine puppy model, pulmonary artery stenosis was created by banding the left 
pulmonary artery to 3040% of its original diameter. Animals underwent right heart cath- 
eterization and angiography 1-2 mo later, and Palmaz P308 stents were implanted. Stent 
redilation was performed 3-5 mo later. One mo postredilation, the animals were restudied 
and sacrificed. Coarctations of the aorta were created by transverse aortic incislon and 
longitudinal repair. P308 stent implantation was performed 2-3 mo later. Stent redilation 
was performed after &lo mo, and the animals were restudied and sacrificed 1-2 mo later. 
Stent implantation was performed in 6 puppies with pulmonary artery stenosis, as 2 
animals developed postoperative pulmonary arterial hypoplasia, precluding stenting. The 
stenosis diameter increased from 4.8 2 0.5 mm to 7.4 4 0.6 mm (mean 2 SE) following 
stenting (P = 0.005), and increased further to 9.2 f 0.7 mm following redilation (P <: 
0.001). There were no significant vessel tears or ruptures. Coarctation stenting was per- 
formed in 8 animals. The coarctation was dilated from 5.8 ? 0.9 mm to 9.8 ? 0.6 mm (P 
' .  O . O O l ) ,  and to 13.5 f 0.5 mm at redilation (P = 0.002). Redilation could not be per- 
formed in 1 animal. Aortic rupture and death occurred in 2 of 7 animals at redilation. 
Stent implantation and redilation in experimental pulmonary artery stenosis appears 
safe and effective. Though stent implantation for coarctation of the aorta appears safe, 
there was a 28% aortic rupture rate at stent redilation in this model. 
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INTRODUCTION 
Endovascular stent therapy has become an important 
interventional technique in the treatment of congenital 
and acquired pulmonary artery stenosis and right ventric- 
ular outflow tract obstruction, particularly in the postop- 
erative patient [ 1-41. There has been little application of 
this technique to congenital aortic anomalies such as co- 
arctation of the aorta [5, 61. The utility of stent therapy 
in the pediatric population may be limited, however, by 
the need to redilate these stainless steel stents in a grow- 
ing child. There are few data addressing the potential for 
stent redilation in normal [7] or abnormal [6] vessels. 
The objectives of this study, therefore, were to demon- 
strate the safety and effectiveness of stent redilation in 
young animal models of pulmonary artery stenosis and 
coarctation of the aorta, and to evaluate the gross ana- 
tomic and histologic results of stent redilation. 
METHODS 
Pulmonary Artery Studies 
Pulmonary artery stenosis creation. Our technique 
for peripheral pulmonary artery stenosis creation has pre- 
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viously been described [8]. Briefly, in 8 mongrel pup- 
pies (weight 800 g), general endotracheal anesthesia was 
induced, using halothane. A left thoracotomy was per- 
formed, and the left pulmonary artery was banded 1-2 
cm from its origin, using two loops of 2-0 vicryl suture. 
The pulmonary artery was narrowed to 30-40% of its 
original diameter. All animals received 3 days of intra- 
muscular antibiotics and pain medications as necessary. 
Pulmonary artery stenting. After a 1-2-mo recovery 
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then advanced across the coarctation. Following pressure 
measurements and angiography, the 7 Fr sheath and 
catheter were exchanged for a 10 Fr 80-100-cm length 
sheath (Cook Inc., Indianapolis, IN). Measurements of 
coarctation, isthmus, and stent diameters were made by 
two investigators (A.M.M., R.H.B.), using the angio- 
graphic catheter as a standard marker. A Palmaz P308 
stent was loaded onto a standard low-pressure angio- 
plasty balloon chosen to yield a balloon-to-isthmus ratio 
of approximately 1 .O. The stent/balloon was positioned 
across the coarctation and inflated to 4-7 atm. Postim- 
plantation single-plane angiograms were then performed. 
The femoral arteries were repaired with 6-0 absorbable 
suture, and the animals received standard regimens of 
antibiotics and pain medications. 
Stent redilation. Stent redilation was performed 6-10 
mo after stent implantation via cutdown of the left fem- 
oral artery. A balloon-to-isthmus ratio of approximately 
1 .O was chosen for redilation, and the stent was redilated 
at low pressure (4-7 atm). After redilation, chronic an- 
tiplatelet or anticoagulation therapy was not used. Fol- 
low-up single-plane angiography and hemodynamic 
measurements were performed 1-2 mo postredilation, 
and the animals were sacrificed for gross anatomic and 
histologic examination. 
Statistics. All data are expressed as mean f 1 SE of 
the mean. Acute changes in gradient and stent diameter 
were evaluated by paired Student’s r-tests. Serial com- 
parisons were evaluated by repeated measures analysis of 
variance. Statistical significance was accepted at P < 
0.05. 
period, the animals underwent percutaneous hemody- 
namic and angiographic studies under surital anesthesia. 
Our technique for pulmonary artery stenting has been 
previously described [8]. Briefly, a Palmaz P308 stent 
(Johnson & Johnson Interventional Systems, Warren, 
NJ) was loaded onto a standard low-pressure balloon 
angioplasty catheter (NuMed, Inc., Hopkinton, NY; 
Mansfield Scientific, Mansfield, MA) chosen to yield a 
balloon to stenosis ratio of between 2-3:l. Measure- 
ments of stenoses and stent dimensions were made by 
two investigators (A.M.M., R.H.B.) using the angio- 
graphic catheter as a standard measure. In all cases, bal- 
loon diameters between 8-10 m were used. The bal- 
loon was inflated to the maximal pressure of 4-7 atm. 
Repeat single-plane angiography and pressure measure- 
ments were performed following stent implantation with 
a standard endhole catheter. The animals received 3 days 
of intramuscular antibiotics and morphine sulfate for 
pain as indicated. 
Stent redilation. The animals underwent stent redila- 
tion 3-5 mo following stent implantation. Complete 
right heart hemodynamic and angiographic studies were 
performed via percutaneous femoral venous access. A 7 
Fr endhole catheter was advanced through the stent to the 
distal left pulmonary artery. In all cases, a standard 
12-mm low-pressure angioplasty balloon (Nu Med, Inc.; 
Mansfield Scientific) was advanced over a 250-cm 
0.035” guidewire to the stent, and the stent was redilated 
using 4-5 atm balloon pressure. Repeat pressure mea- 
surements and single-plane angiography were per- 
formed. One animal was sacrificed immediately follow- 
ing stent redilation. The other animals recovered and 
were treated postoperatively as previously noted. 
Chronic antiplatelet or anticoagulation therapy was not 
employed. The animals were sacrificed 1 mo postredila- 
tion. Gross and histologic tissue examination was then 
undertaken. 
Coarctation Studies 
Coarctation creation. In 16 mongrel puppies general 
endotracheal anesthesia was induced with halothane an- 
esthesia. Through a left lateral thoracotomy, the upper 
descending aorta distal to the left subclavian artery was 
isolated. The aorta was clamped longitudinally with in- 
complete aortic occlusion, and a transverse incision of 
approximately 50% of the diameter of the aorta was 
made. The incision was then repaired longitudinally us- 
ing 5-0 polypropylene running sutures. The animals re- 
ceived 3 days of intramuscular antibiotics and morphine 
sulfate for pain as indicated. 
Coarctation stenting. Stent implantation was per- 
formed 2-3 mo following coarctation creation. The right 
femoral artery was cannulated with a 7 Fr sheath via 
cutdown, and a 7 Fr Berman angiographic catheter was 
RESULTS 
Pulmonary Artery Stenosis 
Pulmonary artery stenting (Table I). All 8 puppies 
survived pulmonary artery banding. Angiography per- 
formed prior to stent implantation disclosed 2 animals 
with severe left pulmonary artery hypoplasia or atresia 
which precluded attempts at stent implantation. At time 
of stent implantation, the animals weighed 30 f 1.8 kg 
(range, 22-33.5 kg). Stent implantation was performed 
in the 6 animals using a balloon-to-stenosis ratio of 2.0 
2 0.2 (range, 1.6-2.7). Following stent implantation, 
stenosis diameter increased from 4.8 f 0.5 mm (range, 
3.4-6.3 mm) to 7.4 2 0.6 mm (range, 5.1-9.4 mm) (P  
= 0.005), and diameter of the pulmonary artery proxi- 
mal to the stenosis (at the proximal stent) increased from 
7.3 2 0.6 mm (range, 5.4-8.8 mm) to 9.6 f 0.4 mm 
(range, 7.9-10.7 mm) (P = 0.004) (Fig. 1). There was 
no angiographic or clinical evidence of pulmonary artery 
rupture, aneurysm, or dissection (Fig. 2A). In one ani- 
mal, flow to a small left upper lobe branch which was 
crossed by the stent appeared compromised but still had 
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Fig. 1. Line graph of changes in pulmonary artery stent diameter (left) and peak systolic 
pressure gradient (right), both at stent implantation and at redilation. Stenosis, left pulmonary 
artery at level of banding. Proximal LPA, region of left pulmonary artery proximal to stenotic 
region 
a small amount of antegrade flow. Otherwise, all other 
pulmonary artery branches were angiographically patent. 
The peak systolic pressure gradient of 13 f 1.4 mm Hg 
across the stenosis prior to stent implantation (range, 
10-17 mm Hg) was reduced to 1.4 f 0.9 mm Hg (0-4 
mm Hg.) (P = 0.003) following stent implantation. 
Pulmonary artery stent redilation. The 6 experi- 
mental animals underwent stent redilation 3.8 * 0.2 mo 
poststent implantation. The animals' weight was 46.3 2 
3.2 kg (range, 31-52 kg), which represents a 54 * 3% 
increase in weight from stent implantation (P < 0.001). 
All stents were redilated using a 12-mm low-pressure 
angioplasty balloon. Two of the 6 stents protruded into 
the main pulmonary artery and could not crossed. These 
2 animals were sacrificed, and the left pulmonary artery 
stent was redilated ex vivo (Table I, animals 2 and 3). 
The stenosis was effectively redilated from 7.4 f 0.4 
mm (range, 5.7-8.6 mm) to 9.2 f 0.7 mm (range, 
8.1-10 mm) (P < 0.001), and the diameter of the left 
pulmonary artery proximal to the stenosis increased from 
9.2 2 0.4 mm (range, 7.7-10 mm) to 11.5 4 0.4 mm 
(range, 10.4-12.8 mm) (P = 0.002). A small residual 
gradient of 3.8 2 1.5 mm Hg (range, 0-8 mm Hg) was 
completely obliterated by stent redilation (Fig. 1). There 
was concomitant increase in the unbanded and unstented 
right pulmonary artery from 11.9 2 0.7 mm at the time 
of left pulmonary artery (LPA) stenting to 14.3 2 0.9 at 
LPA stent redilation (P = 0.04). Stent length decreased 
from 27.4 -t 0.9 mm to 25.7 2 0.8 mm following stent 
redilation (P = 0.01). There were no acute tears, vessel 
ruptures, or arterial dissections identified by follow-up 
angiography (Fig. 2B). In the one animal in whom flow 
to a small upper lobe vessel appeared obstructed after 
stent implantation, no further obstruction to flow was 
noted. 
Coarctation of Aorta 
Coarctation stent implantation (Table 11). Only 8 of 
the initial 16 puppies survived creation of the coarcta- 
tion. Stent implantation was performed in these 8 ani- 
mals 2-3 mo following surgery, when the animals 
weighed 13.8 f 1.3 kg (range, 9.5-19 kg). Balloon 
diameters varied from 10-15 mm, yielding a balloon-to- 
isthmus ratio of 1.07 2 0.07 (range, 0.93-1.1). The 
coarctation was dilated from 5.8 f 0.9 mm (range, 3.7- 
9.5 mm) to 9.8 2 0.6 mm (range, 7.2-12.2 mm) (P < 
0.001) (Fig. 3) with a concomitant increase in the coarc- 
tation-to-isthmus diameter ratio from 0.45 f 0.06 
(range, 0.32-0.68) to 0.78 * 0.03 (range, 0.61-0.88) 
(P = 0.002). There was no significant change in aortic 
diameter proximal to the coarctation following stent im- 
plantation (12.8 f 0.3 mm vs. 12.1 2 0.6 mm). The 
peak systolic gradient across the coarctation fell from 
35.6 f 7.3 mm Hg (range, 15-65 mm Hg) to 2.3 ? 1.3 
mm Hg (range, 0-10 mm Hg) (P = 0.003). There were 
no acute aortic dissections or aneurysms identified by 
angiography (Fig. 4A). 
Coarctation stent redilation. Stent redilation was 
performed 7.2 f 2.5 mo following stent implantation. 
Animal weight had increased to 23.6 f 1.6 kg (range, 
16.4-29.3 kg), which represents a 74 5 7% increase in 
weight (P < 0.001). In one animal (Table 11, animal l),  
the distal stent extended into an area of marked post- 
stenotic dilatation and was not well-apposed to the aortic 
wall, so that during angiography the angiographic cath- 
eter became entrapped through the stent and the stent 
could not be redilated. To avoid distortion of the stent or 
disruption of the aorta, no attempts were made to remove 
the angiographic catheter and the animal was sacrificed. 
The remaining 7 animals underwent stent redilation us- 
ing 14- and 15-mm balloons, which yielded a balloon- 
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Fig. 2. A: Angiograms of animal with pulmonary artery steno- 
sis prior to (left) and following (right) endovascular stenting. 
The pulmonary artery proximal to the stent measured 5.4 mm, 
and the stenosis was 3.4 mm. The left pulmonary artery proxi- 
ma1 to the stenosis following stent implentation with a 9-mm 
balloon measurd 9 mm, and the stenosls was 6.3 mm. The 
10-mm Hg gradient across the left pulmonary artery was abol- 
ished by stent implantation. B: Three and a half mo following 
stent implantation, the stent was redilated with a 12-mm bal- 
loon. The pulmonary artery proximal to the stenosis measured 
10.4 mm, and the stenotic segment was 8.1 mm. A residual 
8-mm Hg gradient was abolished by stent redilation. 
to-isthmus ratio of 1.02 -+ 0.02 (range, 0.93-1.11). The 
coarctation was redilated from 10.1 2 0.6 mm (range, 
7.6-13 mm) to 13.5 2 0.5 mm (range, 11.5-15 mm) (P 
= 0.002), and the diameter of the aorta proximal to the 
coarctation (at the proximal stent) increased from 12.1 -C 
0.5 mm (range, 10.4-14.8 mm) to 14.5 & 0.3 mm 
(range, 14.1-15.2 mm) (P = 0.004) (Figs. 3, 4B). The 
coarctation-to-isthmus diameter ratio increased at redila- 
tion from 0.76 -t 0.04 (range, 0.6-0.9) to 0.9 2 0.02 
(range, 0.88-1) (P = 0.002). The residual peak systolic 
gradient across the coarctation decreased from 6.6 -+ 1.7 
mm Hg (range, 0-13 mm Hg) to 0.4 _+ 0.4 mm Hg 
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Fig. 3. Line graphs demonstrating changes in coarctation stent diameter (left) and systolic 
pressure gradient across the stent (right), following stent implantation and redilation. Proximal 
coa, aorta proximal to the coarctation. Stenosis, coarctation diameter. 
(range, 0-3 mm Hg) (P = 0.002). Stent length de- 
creased from 27.0 +- 0.4 mm to 24.5 * 0.5 mm (P = 
0.003). 
During stent redilation, 2 of the 7 animals (Table 11, 
animals 2 and 5 )  had immediate and fatal aortic rupture 
during balloon inflation. There was no statistical differ- 
ence between these 2 animals and the other 5 experimen- 
tal animals in weight at implantation or redilation, time 
between stent implantation and redilation (7-10 mo), or 
redilation balloon pressure. Both the balloodisthmus di- 
ameter ratio at stent redilation (0.95 k 0.02 vs. 1.04 * 
0.02, P = 0.03) and the coarctation diameters (7.8 * 
0.2 vs. 11.1 2 0.6 mm, P = 0.02) in these 2 animals 
were significantly smaller than in the other 5 animals. 
The balloodcoarctation diameter ratios were signifi- 
cantly larger in the animals with aortic rupture than in the 
other5 animals (2.0 2 0.04 vs. 1.4 5 0.01, P < 0.01). 
and the percentage of increase in coarctation diameter 
following stent redilation was greater in the animals with 
aortic rupture (59.8 2 6.0% vs. 26.6 2 8.5%, P = 
0.07). There was no difference in stent length following 
redilation in the two groups. Autopsy revealed 2-3-mm 
transmural tears 1-2 mm distal to the surgical coarctation 
suture line without disruption or fracture of the stent 
itself. The suture line itself appeared intact by gross in- 
spection and microscopic study. 
Tlssue Studies 
Pulmonary artery stents. Specimens were obtained 
by necropsy 1 mo after stent redilation. There was com- 
plete neointimal coverage of the stent in all cases where 
there was full apposition of stent against the vessel wall. 
The neointima consisted of fibrous tissue covered by a 
thin endothelial cell layer (Fig. 5) .  There were small 
areas of medial calcification in 2 of the 6 pulmonary 
arteries, and microscopic hemosiderin in the media of 4 
of the 6 pulmonary arteries reflecting old bleeding, pos- 
sibly secondary to localized vessel trauma during stent 
implantation. However, there were no medial ruptures or 
aneurysms identified. In the 2 cases where the proximal 
stent extended freely into the main pulmonary artery 
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Fig. 4. A: Angiograms of animal with coarctation of the aorta, 
prior to (left) and following (right) stent implantation. Stenosis 
increased from 4.2 mm to 9.5 mm following stent implantation. 
The aorta proximal to the stenosis measured 12.5 mm both prior 
to and following stent implantation. Gradient reduction from 45 
mm Hg to 0 mm Hg was achieved. 8 :  Angiograms of anlmal wlth 
coarctation of the aorta prior to (left) and following (right) stent 
redllation. Stent redilation was undertaken 10 mo following 
stent implantation, using a balloon-to-isthmus diameter ratio of 
1.1. Coarctation diameter was enlarged from 9.4 to 14.7 mm, and 
proximal stent diameter increased from 12.5 to 14.9 mm. A r e  
sidual 5-mm Hg gradient was abolished at redilation. 
there was incomplete neointimal coverage, and small, 
old, and organized thrombi were present on the nonen- 
dothelialized portions of the stent. In one stent explanted 
immediately following redilation, there were two shal- 
low 2-3-mm intimal tears, with the remainder of the 
stent well-endothelialized (Fig. 6). 
Coarctation stents. In the coarctation stents, there 
was complete neointimal coverage of varying thickness 
when the stent was fully apposed to the aortic wall (Fig. 
7). There was evidence of dystrophic calcification at the 
suture line. All tissues demonstrated microscopic hemo- 
siderin in the media beneath the stent. There were no 
gross or microscopic thrombi, and no aortic aneurysms 
were identified. In the 2 animals with fatal aortic rup- 
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Fig. 5. H&E stain of pulmonary artery 1 mo following stent redilation demonstrates a central 
defect, where the stent arm was located prior to its removal for tissue preparation. A thin 
neointima covers the area of the stent (arrow), composed of fibrous tissue and endothelial cells. 
Fig. 6. Gross anatomical section following acute pulmonary artery stent redilation. There is a thin layer of neointima, and two 
2-3-mm shallow inlimal tears. 
hres there was complete disruption of all layers of the 
aorta (Fig. 8), whereas the media in the remaining 5 
animals was intact though thinned. One stent (which was 
not redilated for technical reasons) had incomplete 
neointimal coverage distally, where it was unapposed to 
the vessel wall in an area of marked poststenotic dilation. 
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Fig. 8. Gross anatomical and histological changes following 
aortic rupture. Above: A 3-mm central transmuraltear through 
the posterior wall of the aorta, without evidence of stent dlsrup- 
tion. The remainder of the stent appears wellendothelialized. 
Below: Utilizing an elastic stain, the transmural rupture is iden- 
tified in close proximity to a suture used to create the model. 
Fig. 7. Gross anatomy (above) and histology (below) of aortic 
coarctation 1 mo following coarctation stent redilation. Above: 
Stent is completely covered by a thin neointima, without evi- 
dence of tears or clots. Below: Thin neointima, with artifactual 
residua of stent wire and a small crescent of elastic lamina. 
DISCUSSION 
Though endovascular stent therapy for congenital 
heart disease has become a valuable tool for treatment of 
resilient vessel stenoses [ 1-4, 9, 101, there remains con- 
cern over the utility of this therapeutic modality in 
young, growing children. This study is the first to show 
that stent redilation appears both safe and effective in an 
experimental model of peripheral pulmonary stenosis. 
Our study was limited by sample size. In 2 of the original 
8 animals, resultant severe pulmonary artery hypoplasia 
from extensive banding precluded attempts at balloon 
angioplasty and thus stent implantation. This situation is 
not uncommonly seen in the clinical spectrum of severe 
pulmonary branch stenosis. Our study design and results 
are also somewhat limited, because stent redilation was 
performed based upon somatic growth of the animals and 
upon relative stent restenosis (when compared to the 
proximal pulmonary artery) rather than true stent reste- 
nosis, which would be more analogous to the clinical 
situation. Lack of true stent restenosis may be intrinsic to 
this particular experimental model and, therefore, how 
these data translate into clinical practice cannot be fully 
determined. Still, in our canine model of peripheral pul- 
monary stenosis, we demonstrated that stents implanted 
at a stenosis diameter of 7.4 2 0.4 mm can eventually be 
redilated to 9.2 k 0.7 mm, a 24% increase in diameter. 
There was histological evidence of shallow intimal tears 
acutely, without full-thickness vessel wall tears, which 
appeared to heal within 1 mo. There were no instances of 
aneurysms or distal vessel occlusion. 
These data lend further experimental support to the 
clinical application of endovascular stent therapy in pa- 
tients with pulmonary artery stenosis or hypoplasia. In 
the largest clinical trial to date, the multicenter study by 
O’Laughlin et al. [2] demonstrated feasibility of stent 
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TABLE II. Results of Coarctation Sent Implantation and Redilation 
Peak systolic 
Weight at Coarctation Peak systolic pressure Weight at Coarctation diameter pressure gradient 
implantation diameter (mm) gradient (mm Hg) Redilation redilation (mm) (mm Hg) 
Animal no. (kg) Re Post Re Post (kg) pre Post Pre Post Comments 
1 19.0 3.4 10.0 65 0 29.3 10 10 Stent not redilated 
2 12.9 3.7 1.5 15 0 21.4 8 12.3 0 0 Aortic rupture 
3 11.3 4.2 9.5 45 0 21.8 9.4 14.7 5 0 
4 19.0 8.2 10.8 15 0 26.8 11.2 15.0 10 3 
5 10.4 4.2 1.2 45 5 20.5 7.6 12.6 10 0 Aortic rupture 
6 12.7 5.1 11.0 60 10 23.2 11.4 13.7 13 0 
7 15.4 9.5 12.2 15 3 29. I 13.0 14.7 5 0 
8 9.5 8.2 10.1 25 0 16.4 10.5 11.5 0 0 
Mean 13.8 5.8 9.8 35.6 2.3 23.6 10.1 13.5 6.6 0.4 
SEM 1.3 0.9 0.6 7.3 1.3 I .6 0.6 0.5 1.7 0.4 
redilation in cases of peripheral pulmonary stenosis and 
systemic venous obstruction in human subjects. The 
gross anatomic and histologic effects of stent redilation 
in these patients, however, were not reported. In our 
study there were small linear intimal tears (Fig. 6) seen 
acutely following dilation in one specimen, which ap- 
peared healed in the other specimens evaluated 1 mo 
following redilation. These histologic findings are anal- 
ogous to the anatomic and histologic changes previously 
reported following balloon angioplasty of experimental 
pulmonary artery stenosis [l 11. In all cases of stent re- 
dilation in our study, there was medial integrity with no 
evidence of dissection or aneurysms. 
This study also evaluated the role of stent implantation 
and redilation in an experimental model of coarctation of 
the aorta. In our study, the coarctation was dilated and 
stented from 5.8 & 0.9 mm to 9.8 2 0.6 mm in diameter 
(P > 0.001), with a similar increase in coarctation-to- 
isthmus diameter ratio from 0.45 2 0.6 to 0.78 * 0.03 
(P = 0.002). In one animal, the angiographic pigtail 
catheter became enmeshed in one of the side holes of the 
stent, making extrusion of the catheter from the stent 
(even with a wire) difficult, and thus this animal was 
sacrificed. This represents a potential technical issue 
with stent implantation in the aorta. Inadequate apposi- 
tion of stent to aortic tissue may leave portions of the 
stent without neointimal covering, leading to catheter 
entrapment within the stent. All attempts should be made 
to implant the stent firmly in the aorta to avoid this 
problem. Unlike our experience with pulmonary artery 
stent redilation, however, redilation of coarctation stents 
was hazardous. There was a 28% (70% CL = 15-48%) 
acute mortality rate at stent redilation due to transmural 
aortic tears occurring in close proximity to the suture 
line. The high incidence of aortic rupture following stent 
redilation in our experimental coarctation model gives 
cause for concern. These data are not particularly con- 
sistent with clinical experience following balloon angio- 
plasty of coarctation (native, or postoperative, which 
may be more similar to our model), in which aortic rup- 
ture has been exceedingly uncommon [ 12,131. Recently, 
Morrow et al. [6] created an experimental model of aor- 
tic coarctation in 1 1  juvenile swine by wedge resection, 
repair with polypropylene suture, and banding of the 
descending aorta. Cardiac catheterization, angioplasty , 
and implantation of PS 308 stents was performed 34 2 
7.8 days following surgery with a resultant 96% increase 
in coarctationlaortic diameter ratio (0.46 2 0.085 to 0.9 
+- 0.122). Stent redilation in 5 animals was performed 59 
-C 6.0 days following implantation, increasing the coarc- 
tationlaortic diameter ratio from 0.774 -t 0.121 to 0.93 
-C 0.11 (P = 0.02). These ratios are similar to those 
achieved in our series. By gross anatomic and histolog- 
ical examination following stent implantation and redi- 
lation, there were severe medial atrophy and aortic nar- 
rowing at the coarctation, but no significant aortic tears, 
ruptures, or thrombotic events. 
In light of findings by Morrow et al. [6], we are con- 
cerned with the high incidence of aortic rupture in our 
model. The only significant difference in the creation of 
the model of Morrow et al. [6] and our own is primarily 
difference in species and, from a technical standpoint, 
addition of an aortic band following wedge resection. 
Still, in both animal models, there was histological evi- 
dence of medial atrophy, and in both, nonabsorbable 
suture was used to create the coarctation. In the porcine 
model, medial changes in the stent group were reportedly 
no different than those observed in a control group fol- 
lowing coarctation creation. In addition, there were no 
significant changes in the neointima and media following 
both primary stent implantation and redilation. In our 
series, there was insufficient aortic tissue remaining in 
the two aortae which ruptured to ascertain whether there 
were similar degrees of medial atrophy when compared 
to the remaining 5 animals. 
In a prior study, Morrow et al. [7] showed that over- 
expansion of endovascular stents implanted in growing 
normal porcine aortae leads to both longitudinal tears in 
the stent and the underlying aortic wall. Contrary to the 
findings in that study, aortic rupture in our animals was 
not associated with stent fracture or stent shortening, but 
rather solely with central transmural aortic tears. Review 
of some of the technical aspects of our experiment may 
shed greater light on these findings. Both the ballood 
isthmus diameter ratios and the coarctation diameters 
themselves in the animals with aortic rupture were sig- 
nificantly smaller at redilation when compared to the 
other experimental subjects, though the coarctatiodisth- 
mus ratios were not significantly different between the 
two animal groups either prior to (0.66 -C 0.06 vs. 0.82 
I+- 0.04) or following (0.88 +- 0 vs. 0.94 * 0.02) stent 
redilation. However, the balloodcoarctation diameter ra- 
tios in these 2 animals with aortic rupture were signifi- 
cantly larger than in the remaining experimental group, 
and the percentage of increase in coarctation diameter 
tended to be greater as well. These data suggest that there 
may be an absolute coarctation diameter below which 
stent redilation may be hazardous, or that stent redilation 
with balloodcoarctation diameter ratios > 1.4 should be 
avoided. 
It is possible that the high rate of aortic rupture ob- 
served in our study is an inherent problem of our exper- 
imental model. There were areas of dystrophic calcifica- 
tion noted along the suture lines, which may indicate 
structural weakness of the vessel wall. The aortic tears 
were in close proximity to the suture line, which was 
composed of nonabsorbable polypropylene sutures. The 
combination of “shearing force” by the redilated stent 
against the coarse, nonabsorbable sutures on the friable 
coarctation tissue may have led to this major complica- 
tion. Out study is limited, because we did not examine 
the role of angioplasty alone in the resultant aortic tears. 
The implications of these findings to the clinical appli- 
cation of stent therapy in patients with coarctation are 
unclear. Caution is warranted, however, particularly in 
patients with postoperative recurrent coarctation, and 
more study of stent redilation is clearly necessary. Fur- 
ther histological studies need to be performed to evaluate 
intimal and media thickness both before and after stent 
implantation to determine if stent implantation leads to 
diminished smooth-muscle and fiber deposition (J.E. 
Lock, Personal communication). 
In summary, we have shown in an experimental model 
of branch pulmonary artery stenosis that endovascular 
stent therapy appears safe at stent implantation and at 
redilation 3.8 mo after stent implantation. Complete 
neointimal coverage of these stents appears contingent 
upon full apposition between the vessel wall and the 
stent, as two stents which extended freely into the main 
pulmonary artery did not have complete neointimal cov- 
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erage, and one stent in a dilated descending aorta led to 
catheter entrapment. Stent implantation in experimental 
coarctation of the aorta also appears safe, with excellent 
gradient reduction and expansion of the coarcted seg- 
ment at initial implantation. In contrast to pulmonary 
artery stent redilation, however, redilation of coarctation 
stents was hazardous. We cannot predict outcomes of 
redilating significant stented stenoses from these data, 
particularly in the coarctation model, which best repre- 
sents lack of stent/coarctation growth rather than signif- 
icant stent restenosis. Certainly our data support the con- 
tention that possible overdilation or use of larger balloon/ 
coarctation diameters ratios may be hazardous in stent 
redilation. Redilation of these stents on the basis of so- 
matic growth rather than recurrence of obstruction and 
increasing systolic gradients should be considered with 
care. Until the causes of our high rate of aortic rupture at 
stent redilation can be ascertained, we recommend stent 
implantation for coarctation of the aorta only in selected 
cases, where the patients are older and may not need 
stent redilation, or in cases where the patients are 
deemed poor surgical candidates, and standard balloon 
angioplasty is unsuccessful. 
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